Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Cash Flow Reinvestment Rate
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Cash Flow Reinvestment Rate of 20.59x as of December 2024, reinvesting CN¥3.02 Billion (capex CN¥1.43 Billion plus investments CN¥-1.59 Billion) from operating cash flow of CN¥146.50 Million. See 605077 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Huakang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Zhejiang Huakang Pharmaceutical Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Huakang Pharmaceutical Co Ltd.
Annual Cash Flow Reinvestment Rate for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Zhejiang Huakang Pharmaceutical Co Ltd. See 605077 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 20.59x | CN¥3.02 Billion | CN¥146.50 Million | CN¥1.43 Billion | ▲ +554.2% |
| 2023 | 3.15x | CN¥1.95 Billion | CN¥619.47 Million | CN¥690.70 Million | ▲ +41.8% |
| 2022 | 2.22x | CN¥603.67 Million | CN¥271.98 Million | CN¥539.75 Million | ▼ -63.7% |
| 2021 | 6.11x | CN¥1.62 Billion | CN¥264.32 Million | CN¥360.93 Million | ▲ +240.8% |
| 2020 | 1.79x | CN¥601.43 Million | CN¥335.24 Million | CN¥252.95 Million | ▲ +130.9% |
| 2019 | 0.78x | CN¥218.54 Million | CN¥281.31 Million | CN¥132.21 Million | ▼ -9.8% |
| 2018 | 0.86x | CN¥121.38 Million | CN¥140.97 Million | CN¥121.38 Million | ▲ +320.6% |
| 2017 | 0.20x | CN¥16.49 Million | CN¥80.56 Million | CN¥16.49 Million | ▼ -24.8% |
| 2016 | 0.27x | CN¥25.32 Million | CN¥93.02 Million | CN¥25.32 Million | — |